Constellation Pharmaceuticals
Utility Patent Applications
Last updated:
List of all Constellation Pharmaceuticals patents 23 in total
| Status | Patent |
|---|---|
Application | Utility: EZH2 INHIBITION IN COMBINATION THERAPIES FOR THE TREATMENT OF CANCERS Filling date: 18 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: CRYSTALLINE FORMS OF 7-CHLORO-2-(4-(3-METHOXYAZETIDIN-1-YL)CYCLOHEXYL)-2,4-DIMETHYL-N-((6-METH- YL-4-(METHYLTHIO)-2-OXO-1,2-DIHYDROPYRIDIN-3-YL)METHYL)BENZO[D][1,3]DIOXOL- E-5-CARBOXAMIDE Filling date: 18 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: P300/CBP HAT INHIBITORS AND METHODS FOR THEIR USE Filling date: 18 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: THERAPEUTIC COMPOUNDS AND USES THEREOF Filling date: 18 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: LSD1 INHIBITORS AND MEDICAL USES THEREOF Filling date: 18 Sep 2025 Issue date: 17 Mar 2022 |
Application | Utility: MODULATORS OF TREX1 Filling date: 18 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF Filling date: 18 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF Filling date: 18 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: EZH2 INHIBITOR-INDUCED GENE EXPRESSION Filling date: 18 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: P300/CBP HAT INHIBITORS Filling date: 18 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: P300/CBP HAT INHIBITORS Filling date: 18 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: METHODS OF TREATING MYELOPROLIFERATIVE DISORDERS Filling date: 18 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: PHARMACOKINETIC ENHANCEMENT OF EZH2 INHIBITORS THROUGH COMBINATION THERAPIES Filling date: 18 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: THERAPEUTIC COMPOUNDS AND USES THEREOF Filling date: 18 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF Filling date: 18 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: LSD1 INHIBITORS AND MEDICAL USES THEREOF Filling date: 18 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: COMBINATIONS OF EZH2 INHIBITORS WITH FURTHER AGENTS FOR USE IN THE TREATMENT OF CANCER Filling date: 18 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: MARKERS FOR PERSONALIZED CANCER TREATMENT WITH LSD1 INHIBITORS Filling date: 18 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: SOLID DISPERSIONS OF (R)-N-((4-METHOXY-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-3-YL)METHYL)-2-METHYL- -1-(1-(1-(2,2,2-TRIFLUOROETHYL)PIPERIDIN-4-YL)ETHYL)-1H-INDOLE-3-CARBOXAMI- DE Filling date: 18 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF Filling date: 18 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: LSD1 INHIBITORS AND MEDICAL USES THEREOF Filling date: 18 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: THERAPEUTIC COMPOUNDS AND USES THEREOF Filling date: 18 Sep 2025 Issue date: 8 Aug 2019 |
Application | Utility: SYNTHESIS OF INHIBITORS OF EZH2 Filling date: 18 Sep 2025 Issue date: 1 Aug 2019 |
Showing 1 to 23 of 23 patents.